Stocks TelegraphStocks Telegraph
Stock Ideas

CGON Stock Performance and Key Statistics

NASDAQ : CGON

CG Oncology

$73.52
4.2+6.06%
At Close 4:00 PM

stock performance chart

CGON Fundamental Analysis

Based on recent data, CG Oncology Inc. (CGON) shows an Average True Range (ATR) of 2.87 and an Enterprise Value of N/A. Its average trading volume over the past 3 months is 1.02M, indicating liquidity. These fundamental metrics provide insight into CGON's underlying financial health and market activity.

ATR2.87
Enterprise Value-
Avg Vol (3 Months)1.02M
Avg Vol (10 Days)770.73K

CGON Technical Analysis Indicators

CG Oncology Inc. (CGON) technical indicators as of July 28, 2026: the SMA 20 is 4.14%, SMA 50 at 13.79%, and SMA 200 at 52.02%. The RSI 14 value is 58.08, suggesting its current momentum. These technical analysis signals help assess CGON's price trends and potential future movements.

SMA 204.14%
SMA 5013.79%
SMA 20052.02%
RSI 1458.08

CGON Stock Performance Overview

CG Oncology Inc. (CGON) stock performance overview as of July 28, 2026: The 52-week high is $77 (currently -6.48% below), and the 52-week low is $23.65 (currently 279.12% above). Over the past year, CGON's performance is 87.94%, compared to the S&P 500's 3.36% change.

52-Week High77
52-Week High Chg-6.48%
52-Week Low23.65
52-Week Low Chg+279.12%
S&P 500 52-Week Chg3.36%

CG Oncology Inc. (CGON) Historical Stock Performance

According to market data, CG Oncology Inc. (CGON) stock's recent performance metrics show that over the last month, CGON is 46.35%, with a Year-to-Date (YTD) performance of 31.72%. Over the past year, the stock has seen a 87.94% change. These figures summarize CGON's price movements across various periods, reflecting its historical returns.

Period1 Week1 MonthQuarterHalf Year1 YearYTD
High73.897777777777
Low6867.4353.2148.5123.6539.14
Performance+1.81%+46.35%+31.91%+103.31%+87.94%+31.72%

Industry Analysis and Valuation

According to current financial data, CGON stock's P/E (TTM) ratio is -30.64, which compares to the S&P 500's P/E of 32.59. The sector median P/E is -1.24. Key valuation ratios for CGON, including P/S (1247.02), P/B (5.55), and P/FCF (-39.42), offer insights into how the company is valued relative to its earnings, sales, book value, and free cash flow.

ValuationCGONSector MedianIndustry AvgS&P 500
P/E (TTM)-30.64-1.24-194.7832.59
P/S (TTM)1247.023.7468.695.98
P/B (TTM)5.550-3496.435.59
P/FCF (TTM)-39.42-0.33-619.5431.65

Frequently Asked Questions

How is CGON price-to-earnings ratio currently?
CGON has a current P/E ratio of -30.64
How are CGON's price-to-sale and price-to-book ratios?
The CGON stock has a trailing twelve month price-to sales (P/S) ratio of 1247.02 while its price-to-book (P/B) value is 5.55.
Is CG Oncology Inc.'s price-to-cashflow ratio high or low?
CGON's price-to-free-cashflow (P/FCF) ratio is -39.42, an indicator that is currently being trending upward.
What's current simple moving average (SMA) for CGON?
Based on CGON's recent bid, its distance from 20 days simple moving average is 4.14%. It is 13.79% apart from 50 days simple moving average, and it is 52.02% apart from 200 days simple moving average.
What is the 52-week price range for CGON?
The 52-week high for CGON is $77.00 which is -6.48% away from the current price level whereas the distance of that from the 52-week low of $23.65 stands at 279.12%.
An overview of CGON's stock performance: how did it fare?
The performance of CGON stock was not encouraging with most of its significant price indicators in green. CG Oncology Inc.(NASDAQ: CGON) shares have moved upward +6.06% or $4.20 in the latest trading session and have gained 31.72% year-to-date (YTD). The stock has gained nearly 87.94% over the past year. After moving 31.91% over the trailing 3-month period, the stock is 103.31% higher in the 6-month period. Looking at its performance over the shorter term, it'sgained 1.81% a week and 46.35% a month.
What is CGON's 14-day relative strength index (RSI)?
The current 14-day RSI for CGON stock is 58.08. Investors and traders alike rely on the relative strength index, or RSI, as an oscillating indicator. In terms of values, the RSI operates within a range ranging from 0 to 100. A rising RSI line indicates strength in the shares. As the RSI line falls, the opposite occurs. It is possible to examine different time periods when using the RSI indicator. Shorter time frames can cause the RSI to be more volatile. Most traders pay close attention to the marks between 30 and 70 on the RSI scale. When the stock price moves over 70, it is often considered to be an indicator of overbought conditions. Dropping below 30 indicates oversold territory. These levels are often used by traders to forecast stock price reversals.
For CGON, what is the average true range (ATR) for the past two weeks?
ATR stands for Average True Range, which may be useful when traders or investors are assessing technical inventory. Currently, CG Oncology Inc. (CGON) has a 14-day ATR of 2.87.
What is CGON's current enterprise value?
After closing at $69.32 with 88.2M of its shares outstanding, the current enterprise value of CGON is roughly -.
Over the past year, how has the stock price of CGON changed?
CG Oncology Inc. (NASDAQ: CGON) is up 87.94% when it comes to the percentage price change over the past 52-weeks. The percentage price change came more than that of broader S&P 500 index that came at a rise of 3.36%. CGON stock price is also up 31.72% on its value in year-to-date trading.
What is the average trading volume for CGON shares?
The number outstanding shares of CGON is 88.2M, and of these 59.76% shares are freely available for trading. On average, CGON stock has traded 770.73K shares per day for the past 10 days. A total of 1.06M shares changed hands during the last trading session with the average session volume of 1.04M shares.
logo

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

© 2026 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep

stockstelegraph

Don't have an account?

stockstelegraph

Don't have an account?

stockstelegraph

Already have an account?

stockstelegraph
Smart Screening Tools for Exceptional Returns
stockstelegraph

For just $1, you can unlock ST Grading’s top-rated stocks that consistently beat the market. Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.

Ready to Win Big?

Try Now for Just $1!
stockstelegraph